Legend Biotech Corp (LEGN) Total Current Liabilities (2019 - 2024)
Legend Biotech (LEGN) has disclosed Total Current Liabilities for 6 consecutive years, with $277.6 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Total Current Liabilities rose 28.29% year-over-year to $277.6 million, compared with a TTM value of $277.6 million through Dec 2024, up 28.29%, and an annual FY2024 reading of $277.6 million, up 28.29% over the prior year.
- Total Current Liabilities was $277.6 million for Q4 2024 at Legend Biotech, up from $216.4 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $297.8 million in Q4 2022 and bottomed at $115.6 million in Q4 2020.
- Average Total Current Liabilities over 5 years is $227.3 million, with a median of $229.2 million recorded in 2021.
- The sharpest move saw Total Current Liabilities soared 98.33% in 2021, then fell 27.32% in 2023.
- Year by year, Total Current Liabilities stood at $115.6 million in 2020, then skyrocketed by 98.33% to $229.2 million in 2021, then rose by 29.92% to $297.8 million in 2022, then fell by 27.32% to $216.4 million in 2023, then grew by 28.29% to $277.6 million in 2024.
- Business Quant data shows Total Current Liabilities for LEGN at $277.6 million in Q4 2024, $216.4 million in Q4 2023, and $297.8 million in Q4 2022.